Terms: = Breast cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Staging
523 results:
1. Inflammatory breast cancer: An overview about the histo-pathological aspect and diagnosis.
Sahraoui G; Rahoui N; Driss M; Mrad K
Int Rev Cell Mol Biol; 2024; 384():47-61. PubMed ID: 38637099
[TBL] [Abstract] [Full Text] [Related]
2. DNA Methylation-Regulated HOXC8's Role in her2-Positive breast cancer Function and its Contribution to Herceptin Resistance.
Xie X; Tang S; Yu Z
Discov Med; 2024 Mar; 36(182):559-570. PubMed ID: 38531796
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
[No Abstract] [Full Text] [Related]
4. Anatomy Versus Biology: What Guides Chemotherapy Decisions in Older Patients With breast cancer?
Record SM; Thomas SM; Tian WM; van den Bruele AB; Chiba A; DiLalla G; DiNome ML; Kimmick G; Rosenberger LH; Woriax HE; Hwang ES; Plichta JK
J Surg Res; 2024 Apr; 296():654-664. PubMed ID: 38359680
[TBL] [Abstract] [Full Text] [Related]
5. Investigating the role of tumour-to-skin proximity in predicting nodal metastasis in breast cancer.
Sivakanthan T; Tanner J; Mahata B; Agrawal A
Breast Cancer Res Treat; 2024 May; 205(1):109-116. PubMed ID: 38308767
[TBL] [Abstract] [Full Text] [Related]
6. [A Case of breast cancer Complicated by Fibrous Dysplasia That Was Difficult to Differentiate from Bone Metastasis].
Makino Y; Otani A; Hikino H; Murata Y; Miura H; Harada A
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1465-1467. PubMed ID: 38303309
[TBL] [Abstract] [Full Text] [Related]
7. BRCA1 methylation in breast duct carcinoma, a practical study in Duhok-Iraq.
Hasan NA; Pity IS
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):34-39. PubMed ID: 38279496
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic yield of contrast-enhanced abdominal staging CT in patients with initially diagnosed breast cancer.
Jeong B; Lee YW; Lee SB; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Gwark S; Shin HJ; Yoo TK; Choi SH
Eur J Radiol; 2024 Feb; 171():111295. PubMed ID: 38241854
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of blood supply and metabolism in tumor, axillary lymph node and normal breast tissue with F-18 FDG PET/CT in breast cancer: comparison with pathological prognostic factors.
Abdulrezzak U; Akgun H; Tutus A; Kula M; Dogan S; Oz AB; Ok E
BMC Womens Health; 2024 Jan; 24(1):45. PubMed ID: 38229093
[TBL] [Abstract] [Full Text] [Related]
10. To study the survival analysis and recurrence pattern in women treated for breast cancer: Retrospective study, a tertiary cancer center experience from Sub-Himalayan Region of India.
Sundram S; Nandi S; Arora A; Saini S
J Surg Oncol; 2024 Apr; 129(5):843-849. PubMed ID: 38221665
[TBL] [Abstract] [Full Text] [Related]
11. Machine learning prediction of pathological complete response and overall survival of breast cancer patients in an underserved inner-city population.
Dell'Aquila K; Vadlamani A; Maldjian T; Fineberg S; Eligulashvili A; Chung J; Adam R; Hodges L; Hou W; Makower D; Duong TQ
Breast Cancer Res; 2024 Jan; 26(1):7. PubMed ID: 38200586
[TBL] [Abstract] [Full Text] [Related]
12. Targeted axillary dissection: worldwide variations in clinical practice.
Kontos M; Kanavidis P; Kühn T; Masannat Y; Gulluoglu B;
Breast Cancer Res Treat; 2024 Apr; 204(2):389-396. PubMed ID: 38175449
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
Xie Y; Lei C; Ma Y; Li Y; Yang M; Zhang Y; Law KN; Wang N; Qu S
BMC Womens Health; 2024 Jan; 24(1):16. PubMed ID: 38172874
[TBL] [Abstract] [Full Text] [Related]
14. Vision Transformers for breast cancer Human Epidermal Growth Factor Receptor 2 Expression staging without Immunohistochemical Staining.
Ayana G; Lee E; Choe SW
Am J Pathol; 2024 Mar; 194(3):402-414. PubMed ID: 38096984
[TBL] [Abstract] [Full Text] [Related]
15. Retrospective analysis of treatment, including access to breast reconstructions, of breast cancer patients - war refugees from Ukraine in Poland - the experience of a single tertiary care institution.
Wow T; Murawa D; Boguszewska-Byczkiewicz K; Burzyński J; Ryk A; Kolacinska A
Pol Przegl Chir; 2023 Mar; 95(6):20-23. PubMed ID: 38058164
[TBL] [Abstract] [Full Text] [Related]
16. Axillary Nodal Response to Neoadjuvant T-DM1 Combined with Pertuzumab in a Prospective Phase II Multi-Institution Clinical Trial.
Weiss A; Jin Q; Waks AG; Yardley D; Spring LM; Wrabel E; Tayob N; Viale G; Krop IE; King TA; Metzger-Filho O
J Am Coll Surg; 2024 Mar; 238(3):303-311. PubMed ID: 38047578
[TBL] [Abstract] [Full Text] [Related]
17. A Population Description of Young Women with breast cancer in Newfoundland and Labrador.
Mahoney M; Sriranganathan S; Dowden J; Seal M
Curr Oncol; 2023 Oct; 30(11):9602-9610. PubMed ID: 37999115
[TBL] [Abstract] [Full Text] [Related]
18. Pathological response in mucinous carcinoma of breast after neoadjuvant therapy - a multi-institutional study.
Zhan H; Fineberg S; Podany P; Zeng J; Wang Y; Harigopal M; Singh K
Hum Pathol; 2023 Dec; 142():15-19. PubMed ID: 37972873
[TBL] [Abstract] [Full Text] [Related]
19. Is There a Survival Difference Between Male and Female breast cancer Subtypes According to the Prognostic staging System? A Population-Based Cohort Study.
Sanli AN; Tekcan Sanli DE; Altundag MK; Aydogan F
Am Surg; 2024 Apr; 90(4):788-799. PubMed ID: 37916470
[TBL] [Abstract] [Full Text] [Related]
20. Pilot study of her2 targeted 64 Cu-DOTA-tagged PET imaging in gastric cancer patients.
Hernandez MC; Yazaki P; Mortimer JE; Yamauchi D; Poku E; Park J; Frankel P; Kim J; Colcher DM; Wong J; Fong Y; Shively J; Woo Y
Nucl Med Commun; 2023 Dec; 44(12):1151-1155. PubMed ID: 37901917
[TBL] [Abstract] [Full Text] [Related]
[Next]
